Publication

European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma.

Zinzani, P
; 
Karlin, L
; ; 
Caballero, D
; 
Fields, P
; 
Chamuleau, M
; 
D' Amore, F
; 
Haioun, C
; 
Thieblemont, C
; 
González-Barca, E
... show 6 more
Citations
Altmetric:
Abstract
Authors
Zinzani, P
Karlin, L
Radford, John A
Caballero, D
Fields, P
Chamuleau, M
D' Amore, F
Haioun, C
Thieblemont, C
González-Barca, E
Grande García, C
Johnson, P
van Imhoff, G
Ng, T
Dwyer, K
Morschhauser, F
Affiliation
Policlinico S. Orsola, University of Bologna, Bologna, Italy
Description
Date
2016-07-14
Publisher
Collections
All Christie Publications
Show all metadata
Keywords
Type
Article
Citation
European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma. 2016: Haematologica
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/618584
Embedded videos